We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Impact of Sucrose Ingestion During Exercise on Liver and Muscle Glycogen Concentration.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02110836
Recruitment Status : Completed
First Posted : April 10, 2014
Last Update Posted : August 7, 2015
Sponsor:
Collaborators:
University of Newcastle Upon-Tyne
Maastricht University
Sugar Nutrition, UK
Information provided by (Responsible Party):
Javier Gonzalez, PhD, Northumbria University

Tracking Information
First Submitted Date  ICMJE April 3, 2014
First Posted Date  ICMJE April 10, 2014
Last Update Posted Date August 7, 2015
Study Start Date  ICMJE April 2014
Actual Primary Completion Date September 2014   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: August 4, 2015)
Change in liver glycogen concentration [ Time Frame: 3 hours ]
The change in liver glycogen concentration will be determined pre-to-post 3 h of exercise using 13C magnetic resonance spectroscopy.
Original Primary Outcome Measures  ICMJE
 (submitted: April 8, 2014)
  • Change in liver glycogen content [ Time Frame: 3 hours ]
    The change in liver glycogen content will be determined pre-to-post 3 h of exercise using 13C magnetic resonance spectroscopy.
  • Change in muscle glycogen content. [ Time Frame: 3 hours ]
    The change in muscle glycogen content will be determined pre-to-post 3 h of exercise using 13C magnetic resonance spectroscopy.
  • Change in intramyocellular lipid content. [ Time Frame: 3 hours ]
    The change in intramyocellular lipid content will be determined pre-to-post 3 h of exercise using 1H magnetic resonance spectroscopy.
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: August 4, 2015)
  • Plasma glucose concentration. [ Time Frame: 3 hours ]
    Plasma glucose concentrations will be determined every 30 min during 3 h of exercise.
  • Plasma lactate concentration [ Time Frame: 3 hours ]
    Plasma lactate concentrations will be determined every 30 min during 3 h of exercise.
  • Plasma non-esterified fatty acid concentration [ Time Frame: 3 hours ]
    Plasma non-esterified fatty acid concentrations will be determined every 30 min during 3 h of exercise.
  • Indirect calorimetry [ Time Frame: 3 hours ]
    Measurements of oxygen consumption, carbon dioxide production and respiratory exchange ratio through indirect calorimetry measured every 30 minutes during exercise.
  • Muscle glycogen concentration [ Time Frame: 3 hours ]
    The change in muscle glycogen concentration will be determined pre-to-post 3 h of exercise using 13C magnetic resonance spectroscopy.
  • Change in intramyocellular lipid concentration [ Time Frame: 3 hours ]
    The change in intramyocellular lipid concentration will be determined pre-to-post 3 h of exercise using 1H magnetic resonance spectroscopy.
Original Secondary Outcome Measures  ICMJE
 (submitted: April 8, 2014)
  • Plasma glucose concentration. [ Time Frame: 3 hours ]
    Plasma glucose concentrations will be determined every 30 min during 3 h of exercise.
  • Plasma lactate concentration [ Time Frame: 3 hours ]
    Plasma lactate concentrations will be determined every 30 min during 3 h of exercise.
  • Plasma non-esterified fatty acid concentration [ Time Frame: 3 hours ]
    Plasma non-esterified fatty acid concentrations will be determined every 30 min during 3 h of exercise.
  • Indirect calorimetry [ Time Frame: 3 hours ]
    Measurements of oxygen consumption, carbon dioxide production and respiratory exchange ratio through indirect calorimetry measured every 30 minutes during exercise.
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE The Impact of Sucrose Ingestion During Exercise on Liver and Muscle Glycogen Concentration.
Official Title  ICMJE Not Provided
Brief Summary

Carbohydrate is stored in the body as glycogen, which is mainly found in the liver and muscle. During endurance exercise, muscle glycogen is used as fuel for the working muscles and liver glycogen is broken down to provide glucose to maintain blood glucose (sugar) levels. Both liver and muscle glycogen are important for the ability to perform intense/prolonged endurance exercise. Therefore, nutritional strategies which can maximise the availability of glycogen in muscle and liver can benefit endurance exercise capacity.

The carbohydrates typically found in sports drinks are glucose and sometimes fructose. If glucose only is ingested during exercise, then the maximum rate at which can be absorbed from the intestine into the blood stream is ~1 g/min. However, if different sources of carbohydrate (fructose) are used, which are absorbed through a different pathway, absorption of carbohydrate can be up to ~1.8 g/min. With more carbohydrate available as a fuel, this translates into an improvement in performance.

Sucrose is a naturally occurring sugar that is made up of a single glucose and single fructose molecule. Therefore, theoretically, this can use the two different pathways of absorption and also maximise carbohydrate delivery. It is not yet known however, what impact this has on our liver and muscle glycogen stores during exercise. Therefore the aim of this study is to assess whether sucrose ingestion influences liver and muscle glycogen depletion during endurance exercise.

Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Basic Science
Condition  ICMJE Liver and Muscle Glycogen Use During Exercise.
Intervention  ICMJE
  • Dietary Supplement: Glucose ingestion
    Glucose ingestion during exercise at 1.8 g/min
  • Dietary Supplement: Sucrose ingestion
    Sucrose ingestion during exercise at 1.8 g/min
Study Arms  ICMJE
  • Active Comparator: Glucose ingestion
    Glucose ingestion during exercise at a rate of 1.8 g/min.
    Intervention: Dietary Supplement: Glucose ingestion
  • Experimental: Sucrose ingestion
    Sucrose ingestion during exercise at a rate of 1.8 g/min.
    Intervention: Dietary Supplement: Sucrose ingestion
Publications * Gonzalez JT, Fuchs CJ, Smith FE, Thelwall PE, Taylor R, Stevenson EJ, Trenell MI, Cermak NM, van Loon LJ. Ingestion of glucose or sucrose prevents liver but not muscle glycogen depletion during prolonged endurance-type exercise in trained cyclists. Am J Physiol Endocrinol Metab. 2015 Dec 15;309(12):E1032-9. doi: 10.1152/ajpendo.00376.2015. Epub 2015 Oct 20.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: August 4, 2015)
14
Original Estimated Enrollment  ICMJE
 (submitted: April 8, 2014)
15
Actual Study Completion Date  ICMJE April 2015
Actual Primary Completion Date September 2014   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Healthy
  • Male
  • 18 - 35 years of age
  • Endurance trained cyclist/triathlete
  • VO2 max ≥ 50 ml/kg/min

Exclusion Criteria:

  • Use of medication
  • Smoking
  • Metabolic disorders
Sex/Gender  ICMJE
Sexes Eligible for Study: Male
Ages  ICMJE 18 Years to 35 Years   (Adult)
Accepts Healthy Volunteers  ICMJE Yes
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE United Kingdom
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT02110836
Other Study ID Numbers  ICMJE NUSUCA
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE Not Provided
Current Responsible Party Javier Gonzalez, PhD, Northumbria University
Original Responsible Party Same as current
Current Study Sponsor  ICMJE Javier Gonzalez, PhD
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE
  • University of Newcastle Upon-Tyne
  • Maastricht University
  • Sugar Nutrition, UK
Investigators  ICMJE
Principal Investigator: Luc van Loon, PhD Maastricht University
PRS Account Northumbria University
Verification Date August 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP